Sarah Thibault-Sennett

Senior Director of Reimbursement Policy @ American Clinical Laboratory Association (@ACLAlabs). Tweets are my own. Retweets are not an endorsement.

[American Clinical Laboratory Association @ACLAlabs]

Every day, laboratorians across the country deliver essential health information to patients and providers. This #LabWeek, we recognize their important role informing evidence-based health care decisions. @ASCLS

[American Clinical Laboratory Association @ACLAlabs]

We thank America’s laboratorians for their tireless efforts each day to deliver essential health information to providers and patients across the country. #LabWeek #ThePowerofKnowing

[American Clinical Laboratory Association @ACLAlabs]

Join us in welcoming Sarah Thibault-Sennett (@ThibaultSennett), PhD, as Senior Director of Reimbursement Policy. Full announcement available here: https://t.co/k4nB4JqQ1E.

[Association for Molecular Pathology @AMPath]

¿Te has preguntado alguna vez qué ocurre cuando se analizan muestras biomédicas personales? Explora nuestro gráfico traducido y descúbrelo. #molpath
Gráfico: https://t.co/ZzzOn4rCVu

[Association for Molecular Pathology @AMPath]

AMP se complace en anunciar que el gráfico "laboratorio clínico de diagnóstico molecular" está disponible en Español. Si tienes alguna pregunta sobre patología molecular o ideas para nuevas traducciones, pónte en contacto con nosotros [[email protected]].
https://t.co/M46kUbRjgH

[Association for Molecular Pathology @AMPath]

“If Congress gives the FDA authority to enforce needless regulatory hurdles for laboratory developed tests, it would make the U.S. less prepared for future pandemics...” - @WSJ https://t.co/7HSoyL5cNV
#VALIDAct

[Association for Molecular Pathology @AMPath]

New #PAMA cuts could undermine lab infrastructure needed for delivery of routine care, public health while dampening innovation. The Saving Access to Laboratory Services Act will help protect millions of seniors’ access to vital services: https://t.co/TVSrnQpKAf. #StopLabCuts

[Association for Molecular Pathology @AMPath]

Share insights regarding #PAMA's impact on YOUR lab with AMP! To advocate for improved payment rates & effective reform, we urgently need input from the community. Please participate in this anonymous survey today! #StopLabCuts #molpath #pathologists https://t.co/odEi7fueoT

[Association for Molecular Pathology @AMPath]

Today’s the day! AMP’s Virtual Advocacy Day is kicking off with members tuning in from all over the country. We’re ready for a busy day advocating for the molecular community and the patients we serve! #AMPAdvocates #molpath #pathtwitter

[Association for Molecular Pathology @AMPath]

Act now! Tell your Senators you oppose the Verifying Accurate Leading-edge IVCT Development (VALID) Act and its inclusion in must-pass #MDUFA legislation: https://t.co/O5K7K73JcI #molpath #LDPs #pathtwitter

[Sarah Thibault-Sennett @ThibaultSennett]

Roses are Red,
February is Gray,
@AMPath is accepting applications for our Policy Fellowship Program,
Apply today! https://t.co/2WG5VkPTVC
#SciPolJobs #PublicHealthJobs #HealthPolicyValentines

[Sarah Thibault-Sennett @ThibaultSennett]

Feel free to contact me with any questions! Our team is highly self-motivated, enthusiastic, and committed to excellence. Online application can be accessed here: https://t.co/LmafE0INKo

[Sarah Thibault-Sennett @ThibaultSennett]

Come work with the @AMPath Public Policy & Advocacy Team!!! We are currently accepting applications for the AMP Policy Fellowship Program. Position description, including fellowship activities, qualifications, and application requirements here: https://t.co/oib6X4ou5T

[Sarah Thibault-Sennett @ThibaultSennett]

The fellowship provides opportunities for early career scientists or professionals to gain skills and experience in and exposure to a variety of policy issues and aspects affecting molecular laboratory medicine.

[Sarah Thibault-Sennett @ThibaultSennett]

Interested in public policy and clinical genetic testing? Apply to join the amazing @AMPath team as a public policy fellow! Learn more here: https://t.co/U9gFY2GgqB

[Association for Molecular Pathology @AMPath]

"The U.S. is once again facing a testing shortage, which will only be further exacerbated by FDA’s plans to pull what the agency deems to be “non-priority #COVID19 tests” off the market as early as February... Now is not the time to reduce laboratory capacity."

[Association for Molecular Pathology @AMPath]

Two years ago, AMP members visited Capitol Hill to advocate for #molpath professionals and the patients we serve. On December 8, we look forward to meeting again (virtually) with our members’ elected representatives! #AMPAdvocates #pathologists

[Association for Molecular Pathology @AMPath]

AMP sends heartfelt thanks today to everyone working to protect and advance public health, especially to our members who work in public health labs. Your efforts save lives. Happy Public Health Thank You Day! #PHTYD #PublicHealthHeroes #molpath

[Association for Molecular Pathology @AMPath]

Join AMP on November 15-19, 2021 for the AMP 2021 Digital Experience, a week of select annual meeting programming and free corporate workshops. We hope to "see" you there! https://t.co/VqssiqyLle #molpath